NIOX Group Company Description

NIOX Group Plc engages in the design, development, and commercialization of medical devices for the measurement of fractional exhaled nitric oxide (FeNo) worldwide.

Its products include NIOX VERO, a non-invasive and point-of-care system that comprises a small portable device and a range of consumables, including sensors, individual disposable mouthpieces, and breathing handles for the measurement of FeNo level in patients.

The company was formerly known as Circassia Group Plc and changed its name to NIOX Group Plc in September 2022.

NIOX Group Plc was incorporated in 2006 and is headquartered in Oxford, the United Kingdom.

NIOX Group Plc

Country	United Kingdom
Founded	2006
Industry	Medical - Equipment & Services
Sector	Healthcare
Employees	92
CEO	Jonathan Emms

Contact Details

Address: Hayakawa Building Oxford, OX4 4GB United Kingdom
Phone	44 3303 309 356
Website	investors.niox.com

Stock Details

Ticker Symbol	NIOX
Exchange	London Stock Exchange AIM
Fiscal Year	January - December
Reporting Currency	GBP
ISIN Number	GB00BJVD3B28
SIC Code	2836

Key Executives

Name	Position
Jonathan Emms	Chief Executive Officer
Michael Roy Roller	Chief Financial Officer
Jonathan Emms	Chief Operating Officer